In 2024, significant advancements have been made in the understanding, prevention, and treatment of lung cancer. These developments encompass novel therapeutic approaches, improved patient outcomes, and enhanced preventive strategies. Recent Discoveries in Lung Cancer Treatment Subcutaneous Formulation of Keytruda: Merck & Co. Inc. announced promising results from a Phase 3 trial of a new subcutaneous formulation of its leading cancer…